haha whatever.
for those that think they are on the cusp of accelerated approval, I point you back to the tone and cadence of the ODAC briefs by the FDA.
Absolute takedown...and it hasn’t aged a bit
Ann: Remestemcel-L for COVID-19 MIS-C published in Pediatrics, page-69
-
- There are more pages in this discussion • 355 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
0.005(0.43%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.20 | $1.15 | $1.879M | 1.604M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 373 | $1.17 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 56269 | 13 |
View Market Depth
| Last trade - 12.14pm 16/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |